Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
Related Drugs
Compound fluorouracil injection
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil injection
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
Shenyang Yaoda Leiyunshang Pharmaceutical Co., Ltd.
Semustine Capsules
Indication: This product is highly fat-soluble and can pass through the blood-brain barrier and enter the cerebrospinal fluid. It is often used for primary brain tumors and metastatic tumors. It can be used in combination with other drugs to treat malignant lymphoma, gastric cancer, colorectal cancer, and melanoma.
Manufacturer:
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Semustine Capsules
Indication: This product is highly fat-soluble and can pass through the blood-brain barrier and enter the cerebrospinal fluid. It is often used for primary brain tumors and metastatic tumors. It can be used in combination with other drugs to treat malignant lymphoma, gastric cancer, colorectal cancer, and melanoma.
Manufacturer:
Tonghua Mao Xiang Pharmaceutical Co., Ltd.